DRUGMATRIX measures CYP450, 2C9 enzyme inhibition using 3-Cyano-7-ethoxycoumarin substrate. It targets a single protein and is an in vitro binding assay using BTI-TN-5B1-4 cells. Does the molecule work for the assay?